QNZ46
-
Catalog numberB2007-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(E)-4-(6-methoxy-2-(3-nitrostyryl)-4-oxoquinazolin-3(4H)-yl)-benzoic acid
-
DescriptionQNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC₅₀ values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively)
-
CAS Number1237744-13-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₄H₁₇N₃O₆
-
Molecular Weight443.42
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA NR2C/NR2D-selective NMDA receptor non-competitive antagonist
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID46861929
-
SMILESCOC1=CC2=C(C=C1)N=C(N(C2=O)C3=CC=C(C=C3)C(=O)O)C=CC4=CC(=CC=C4)[N+](=O)[O-]
-
InChiInChI=1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14H,1H3,(H,29,30)/b12-5+
-
InChi KeyGNLVJIICVWDSNI-LFYBBSHMSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameQNZ46
-
Alternative nameQNZ46
-